- Home
- ATLX vs RNXT Comparison
ATLX vs RNXT Comparison
Compare ATLX & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATLX | RNXT |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.2M | 79.4M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ATLX | RNXT |
|---|---|---|
| Price | $1.66 | $1.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.13 |
| AVG Volume (30 Days) | 301.7K | ★ 396.2K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.08 | 20.00 |
| EPS | N/A | ★ N/A |
| Revenue | $92,491.00 | ★ $1,123,000.00 |
| Revenue This Year | $8.12 | $244.84 |
| Revenue Next Year | $217,536.00 | $195.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2511.63 |
| 52 Week Low | $1.80 | $0.70 |
| 52 Week High | $6.72 | $2.59 |
Technical Indicators
Market Signals| Indicator | ATLX | RNXT |
|---|---|---|
| Relative Strength Index (RSI) | 27.49 | 47.55 |
| Support Level | N/A | $0.83 |
| Resistance Level | $2.63 | $1.51 |
| Average True Range (ATR) | 0.17 | 0.10 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 3.30 | 57.67 |
Price Performance
Historical ComparisonAbout ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project, located in Minas Gerais State in Brazil. The company is focused on producing and selling lithium concentrate, a key ingredient for the battery supply chain.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.